Solitary Fibrous Tumors: 2016 Imaging Update

Abhishek R Keraliya; Sree Harsha Tirumani; Atul B Shinagare; Atif Zaheer; Nikhil H Ramaiya

doi:10.1016/j.rcl.2015.12.006

Solitary Fibrous Tumors: 2016 Imaging Update

Radiol Clin North Am. 2016 May;54(3):565-79. doi: 10.1016/j.rcl.2015.12.006.

Authors

Abhishek R Keraliya¹, Sree Harsha Tirumani², Atul B Shinagare², Atif Zaheer³, Nikhil H Ramaiya²

Affiliations

¹ Department of Imaging, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. Electronic address: akeraliya@partners.org.
² Department of Imaging, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.
³ The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA.

PMID: 27153789
DOI: 10.1016/j.rcl.2015.12.006

Abstract

Optimal management of solitary fibrous tumor requires a multidisciplinary approach with proper histopathological mapping and use of various imaging modalities for exact delineation of primary tumor and metastatic disease if present. In this article, the authors present a comprehensive review of the spectrum of imaging findings of solitary fibrous tumors involving various organ systems and discuss the role of molecular targeted therapies in the management of metastatic disease.

Keywords: CT; MR imaging; Molecular targeted therapies; Solitary fibrous tumor.

Publication types

Review

MeSH terms

Evidence-Based Medicine
Humans
Magnetic Resonance Imaging / methods*
Molecular Targeted Therapy / methods*
Solitary Fibrous Tumors / diagnostic imaging*
Solitary Fibrous Tumors / therapy*
Tomography, X-Ray Computed / methods*
Treatment Outcome